XML 29 R15.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes
12 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes

7. Income Taxes

Income tax expense consists of the following for the years ended March 31:

 

 

 

(In thousands)

 

 

 

2024

 

 

2023

 

Current:

 

 

 

 

 

 

Federal

 

$

-

 

 

$

22

 

State

 

 

-

 

 

 

10

 

Total current

 

 

-

 

 

 

32

 

Deferred:

 

 

 

 

 

 

Federal

 

 

-

 

 

 

708

 

State

 

 

-

 

 

 

677

 

Total deferred

 

 

-

 

 

 

1,385

 

Income tax expense

 

$

-

 

 

$

1,417

 

 

The net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes are reflected in deferred income taxes. Significant components of the Company’s deferred tax assets consist of the following as of March 31:

 

 

 

(In thousands)

 

Deferred Tax Assets

 

2024

 

 

2023

 

Allowance for credit losses not currently deductible
   for tax purposes

 

$

-

 

 

$

4,538

 

Unrealized fair value adjustment

 

 

4,162

 

 

 

-

 

Share-based compensation

 

 

30

 

 

 

20

 

Federal and state net operating loss carryforwards

 

 

9,816

 

 

 

4,812

 

Right of use liability

 

 

15

 

 

 

43

 

Other items

 

 

50

 

 

 

87

 

Valuation allowance

 

 

(14,047

)

 

 

(9,457

)

Total deferred tax assets

 

 

26

 

 

 

43

 

 

 

 

 

 

 

 

Deferred tax liabilities

 

 

 

 

 

 

Right of use asset

 

 

15

 

 

 

43

 

Other items

 

 

11

 

 

 

-

 

Total deferred tax liabilities

 

 

26

 

 

 

43

 

Deferred income taxes

 

$

-

 

 

$

-

 

 

Income tax expense reflects an effective U.S. tax rate, which differs from the corporate tax rate for the following reasons:

 

 

 

(In thousands)

 

 

 

2024

 

 

2023

 

Income tax benefit at Federal statutory rate

 

$

(4,355

)

 

$

(6,838

)

Increase (decrease) resulting from:

 

 

 

 

 

 

Change in valuation allowance

 

 

4,590

 

 

 

9,457

 

State income taxes, net of Federal benefit

 

 

(770

)

 

 

(1,207

)

Other

 

 

535

 

 

 

5

 

Income tax expense

 

$

-

 

 

$

1,417

 

 

Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. A significant piece of negative evidence evaluated was the cumulative pre-tax loss over the three-year period ended March 31, 2024. As of March 31, 2024, a full valuation allowance was recorded against the Company’s net deferred tax asset. The federal net operating loss ("NOL") generated for the year ended March 31, 2024 will carryforward indefinitely. Generally, state NOLs begin to expire March 31, 2039.

The Company considers the earnings of the Company’s U.S. subsidiaries to be indefinitely invested outside Canada on the basis of estimates that future domestic cash generation will be sufficient to meet future domestic cash needs and the Company’s specific plans for reinvestment of those subsidiary earnings. The Company has not recorded a deferred tax liability related to the Canadian income taxes and U.S. withholding taxes on approximately $100.4 million of undistributed earnings of the U.S. subsidiaries indefinitely invested outside Canada. When the Company repatriates the U.S. earnings, it would need to adjust its income tax provision as the earnings will no longer be indefinitely invested outside of Canada. If the Company decided to repatriate the U.S. earnings, it would need to adjust its income tax provision in the period the Company determined that the earnings will no longer be indefinitely invested outside of Canada.